Abstract | OBJECTIVE: METHODS: Totally 100 children hospitalized for pneumonia were randomized equally into 2 groups, namely group A with maxipime treatment at the dose of 50 mg/kg given intravenously twice daily, and group B with sulperazone treatment at 50-100 mg/kg given intravenously twice a day. The therapeutic effects and safety of both medications were observed. RESULTS: In maxipime group, 44 of the 50 cases were cured with complete elimination of the symptoms and signs, and obvious therapeutic effect was achieved in 5 cases with significant improvement or resolution of the majority of symptoms and signs. One case failed to respond favorably to the treatment, with the overall efficacy rate of 98% without incidence of adverse effects. In sulperazone group, 40 of the 50 cases were cured, 6 showed significant improvement, and 4 failed to respond to the treatment, with the rate of 92%. One patient complained of rashes during sulperazone treatment, which disappeared the next day without sulperazone withdrawal. Significant difference was not noted between the groups (chi(2)=2.43, P>0.05). CONCLUSIONS:
|
Authors | Jian-jun Huang, Qiang Zeng, Jia-lu Yu |
Journal | Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA
(Di Yi Jun Yi Da Xue Xue Bao)
Vol. 25
Issue 9
Pg. 1199-200
(Sep 2005)
ISSN: 1000-2588 [Print] China |
PMID | 16174597
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Bacterial Agents
- Cephalosporins
- Cefoperazone
- Cefepime
- Sulbactam
|
Topics |
- Anti-Bacterial Agents
(therapeutic use)
- Cefepime
- Cefoperazone
(administration & dosage, therapeutic use)
- Cephalosporins
(therapeutic use)
- Child
- Child, Preschool
- Drug Therapy, Combination
- Female
- Humans
- Infant
- Male
- Pneumonia, Bacterial
(drug therapy)
- Sulbactam
(administration & dosage, therapeutic use)
|